Market Place
Sourcing Support
National AIDS Memorial, Gilead Launch HIV Education Initiative
11 Jun 2026 //
BUSINESSWIRE
Merck, Gilead Update Phase 3 KEYNOTE-D46/EVOKE-03 Study Final
09 Jun 2026 //
PRESS RELEASE
Gilead and Merck Show Positive Phase 3 Data for Weekly HIV Pill
08 Jun 2026 //
PRESS RELEASE
Gilead Backs Lenacapavir HIV Prevention Launch in South Africa
05 Jun 2026 //
PRESS RELEASE
Gilead and Lakefront Complete Acquisition of Ouro Medicines
04 Jun 2026 //
GLOBENEWSWIRE
Cencora to Handle U.S. Distribution for Kite`s CAR T Therapies
02 Jun 2026 //
BUSINESSWIRE
Gilead`s Livdelzi Succeeds in Rare Liver Trial, Eyes Wider Use
02 Jun 2026 //
FIERCE PHARMA
Tubulis Shares Updated Ovarian Cancer ADC Data at ASCO 2026
30 May 2026 //
FIERCE BIOTECH
Gilead Drops Lead Arthritis Drug from $405M MiroBio Deal
29 May 2026 //
FIERCE BIOTECH
Gilead`s Livdelzi Shows High ALP Normalization in ASSURE Data
27 May 2026 //
BUSINESSWIRE
Orsini Named Specialty Pharmacy for Gilead`s Hepcludex
26 May 2026 //
PR NEWSWIRE
Gilead’s Biologics Hepcludex Receives Approval in US
22 May 2026 //
FDA
Gilead Gets CHMP Backing for Trodelvy in 1st Line Breast Cancer
22 May 2026 //
BUSINESSWIRE
Gilead`s Hepcludex is first FDA-approved treatment for HDV
22 May 2026 //
PRESS RELEASE
Gilead Renews WHO Partnership to Fight Deadly Kala-Azar
22 May 2026 //
FIERCE PHARMA
Gilead Sciences Completes Acquisition of Tubulis
22 May 2026 //
PHARMIWEB
Gilead & Kite Show ADC and Cell Therapy Data at ASCO, EHA 2026
21 May 2026 //
BUSINESSWIRE
Gilead Inks $140M Deal With Korean API Maker Yuhan
21 May 2026 //
FIERCE PHARMA
Gilead Prices $3 Billion of Senior Unsecured Notes
14 May 2026 //
BUSINESSWIRE
Gilead to Present PBC and Viral Hepatitis Data at EASL 2026
13 May 2026 //
BUSINESSWIRE
Gilead Raises Yeztugo`s Debut-Year Sales Expectations
08 May 2026 //
BIOSPACE
Gilead Laying off Vast Majority Of Arcellx Employees
08 May 2026 //
BIOSPACE
Gilead Sciences Announces First Quarter Financial Results
07 May 2026 //
PHARMIWEB
Gilead Cuts Arcellx Team; BioNTech Closures Affect 1,860 Jobs
06 May 2026 //
BIOSPACE
Gilead Earnings Rise as Florida AIDS Drug Program Falters
05 May 2026 //
BUSINESSWIRE
Gilead Sciences to Present at Q2 2026 Investor Conferences
01 May 2026 //
BUSINESSWIRE
FDA Grants Priority Review for Gilead`s Once-Daily HIV Combo
29 Apr 2026 //
BUSINESSWIRE
Gilead Closes Arcellx Acquisition Ahead of Anito-cel Launch
28 Apr 2026 //
BUSINESSWIRE
AHF Files Gilead Shareholder Resolution on Patent Clarity
27 Apr 2026 //
BUSINESSWIRE
EMA Approves Safety Updates for Kite`s Yescarta, Tecartus
24 Apr 2026 //
FIRSTWORD PHARMA
Gilead to Release Q1 2026 Financial Results on May 7
22 Apr 2026 //
BUSINESSWIRE
Gilead Loosens Ties To Arcus As TIGIT Dream Ends In Ph. 3 Fail
21 Apr 2026 //
FIERCE BIOTECH
Arcus Reports Another TIGIT Failure as Gilead Steps Back
20 Apr 2026 //
FIERCE BIOTECH
Gilead declines another Arcus option after Phase 3 TIGIT fail
20 Apr 2026 //
ENDPOINTS
Marengo Reports Phase 2 Invikafusp Data, STAR Program at AACR
17 Apr 2026 //
PR NEWSWIRE
Gilead Clears All Regulatory Hurdles for Arcellx Acquisition
17 Apr 2026 //
BUSINESSWIRE
MSF Slams Gilead`s Lenacapavir Supply in PolyPeptide Review
16 Apr 2026 //
ENDPOINTS
MSF Decries Gilead`s Revised Yeztugo Access Plan
15 Apr 2026 //
FIERCE PHARMA
PEPFAR, Global Fund expand access to Gilead’s lenacapavir
14 Apr 2026 //
BUSINESSWIRE
Global Fund Expands Commitment To Improve Access To HIV Drug
14 Apr 2026 //
REUTERS
Kymera Announces Gilead’ Option Exercise to License KT-200
10 Apr 2026 //
ENDPOINTS NEWS
Cartography`s Strategic First Option Target Exercise with Gilead
09 Apr 2026 //
PHARMIWEB
Gilead Exercises Kymera`s KT-200 Option
09 Apr 2026 //
GLOBENEWSWIRE
Tempus Announces Collab with Gilead to Advance Oncology R&D
09 Apr 2026 //
BUSINESSWIRE
Gilead Pays Kymera $45M For Preclinical Protein Degrader
09 Apr 2026 //
FIERCE BIOTECH
Gilead to buy Germany`s Tubulis for up to $5 billion
07 Apr 2026 //
PRESS RELEASE
Gilead Lays Off Employees At California Headquarters
03 Apr 2026 //
BIOSPACE
Gilead Cancels HIV Trial As Clinical Hold Remains Intact
01 Apr 2026 //
FIERCE BIOTECH
Gilead Extends Tender Offer to Acquire Arcellx
01 Apr 2026 //
BUSINESSWIRE
Galapagos, Gilead Partner On 1st-In-Class T Cell Engager Program
31 Mar 2026 //
GLOBENEWSWIRE
BMS, Novartis, Gilead, Iovance Dinged In CBER Untitled Letters
30 Mar 2026 //
FIERCE PHARMA
Gilead Sciences to Acquire Ouro Medicines
26 Mar 2026 //
BUSINESSWIRE
Gilead Inks Manta Pact To Dive Deeper Into Cancer Patient Aid
24 Mar 2026 //
FIERCE PHARMA
Gilead Chief Gets 20% Pay Bump, Still Falls Short Of $30M Club
24 Mar 2026 //
BIOSPACE
Gilead Sciences to Acquire Ouro Medicines for Autoimmune Diseases
23 Mar 2026 //
BUSINESSWIRE
Gilead Boosts CEO O`Day`S 2025 Compensation By 20% To $28.4M
23 Mar 2026 //
FIERCE PHARMA
Gilead Turns Down Assembly`s Ph. 1-Stage HBV Antiviral
21 Mar 2026 //
FIERCE BIOTECH
Gilead Turns Down Assembly`s Ph. 1-Stage HBV Antiviral
20 Mar 2026 //
FIERCE BIOTECH
Manufacturing Is Key To Gilead`s Yeztugo Prep Rollout: Exec
13 Mar 2026 //
FIERCE PHARMA
Gilead Foundation Awards $12M for HIV Prevention Programs
02 Mar 2026 //
PHARMIWEB
